|Inactivated poliovirus vaccine||Vaccine|
|Trade names||Pentacel, Pediacel, Infanrix IPV + Hib, others|
|AHFS/Drugs.com||FDA Professional Drug Information|
DTaP-IPV/Hib vaccine is a 5-in-1 combination vaccine that protects against diphtheria, tetanus, whooping cough, polio, and Haemophilus influenzae type B.
Its generic name is 'diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and haemophilus B conjugate vaccine', and it is also known as DTaP-IPV-Hib.
DTaP-IPV/Hib vaccine is administered to young children to immunise against diphtheria, tetanus, pertussis, poliomyelitis, and diseases caused by Haemophilus influenzae type B.
A branded formulation marketed in the United States is Pentacel, manufactured by Sanofi Pasteur.
Pentacel is known in the UK and Canada as Pediacel.
An equivalent vaccine marketed in the UK and Canada by GlaxoSmithKline is Infanrix IPV + Hib. This is a two-part vaccine. The DTaP-IPV component is supplied as a sterile liquid, which is used to reconstitute lyophilized (freeze-dried) Hib vaccine.
Pentaxim is a liquid formulation marketed by Sanofi Pasteur.
It is only licensed for young children. In the US the FDA have approved the vaccine for children from age 6 weeks up to age 5 years. It was used in the UK until 2017, following which a 6-in-1 vaccine became available containing the additional protection against Hepatitis B.
- ↑ 1.0 1.1 1.2 1.3 "Diphtheria and Tetanus Toxoids, Acellular Pertussis, Poliovirus and Haemophilus b Conjugate Vaccine". Drugs.com. Archived from the original on 15 July 2018. Retrieved 15 July 2018.
- ↑ 2.0 2.1 "5-in-1 Vaccine (also called Pentavalent Vaccine)". Vaccine Knowledge Project. 3 January 2021. Archived from the original on 19 December 2021. Retrieved 3 July 2018.
- ↑ "Pentacel". U.S. Food and Drug Administration(FDA). STN 125145. Archived from the original on 8 September 2018. Retrieved 15 July 2018.
- ↑ "Pediacel syringe - Summary of Product Characteristics (SmPC)". Datapharm. 17 April 2019. Archived from the original on 17 October 2019. Retrieved 16 October 2019.
- ↑ 5.0 5.1 "Diphteria Toxoid: Canadian Immunization Guide". Public Health Agency of Canada. December 2014. Archived from the original on 24 September 2019. Retrieved 16 October 2019.
- ↑ Plotkin SA, Liese J, Madhi SA, Ortiz E (July 2011). "A DTaP-IPV//PRP∼T vaccine (Pentaxim): a review of 16 years' clinical experience". Expert Rev Vaccines. 10 (7): 981–1005. doi:10.1586/erv.11.72. PMID 21749196. S2CID 207224675.
- ↑ "Diphtheria toxoid / haemophilus b conjugate (prp-t) vaccine / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid (Pentacel) Use During Pregnancy". Drugs.com. Archived from the original on 26 November 2020. Retrieved 2 January 2021.
- Pages using duplicate arguments in template calls
- Use dmy dates from October 2019
- Articles with invalid date parameter in template
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- Portal templates with all redlinked portals
- Combination drugs
- Combination vaccines
- Whooping cough
- All stub articles
- Vaccine stubs